Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide

Nature Biotechnology

Volumn 21, Issue 11, 2003, Pages 1343-1346

  Kuberan, Balagurunathan ^a   Lech, Miroslaw Z ^a   Beeler, David L ^a   Wu, Zhengliang L ^a   Rosenberg, Robert D ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; MOLECULAR STRUCTURE; PATHOLOGY;

ENZYMATIC SYNTHESIS;

ENZYMES;

ANTITHROMBIN III; OLIGOSACCHARIDE; PROTEOHEPARAN SULFATE;

ARTICLE; BIOENGINEERING; BIOSYNTHESIS; CLONING; GOLGI COMPLEX; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANTITHROMBIN III; BIOMIMETICS; CLONING, MOLECULAR; GOLGI APPARATUS; HEPARAN SULFATE PROTEOGLYCANS; MOLECULAR WEIGHT; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN ENGINEERING; RACEMASES AND EPIMERASES; RECOMBINANT PROTEINS; SULFOTRANSFERASES;

EID: 0242385433     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt885     Document Type: Article

References (22)

1. Bernfield, M. et al. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777 (1999).
2. Capila, I. & Linhardt, R.J. Heparin-protein interactions. Angew. Chem. Intl. Edn. 41, 391-412 (2002).
3. Damus, P.S., Hicks, M. & Rosenberg, R.D. Anticoagulant action of heparin. Nature 246, 355-357 (1973).
4. Rosenberg, R.D. & Damus, P.S. The purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 248, 6490-6505 (1973).
5. Atha, D.H., Stephens, A.W. & Rosenberg, R.D. Evaluation of critical groups required for the binding of heparin to antithrombin. Proc. Natl. Acad. Sci. USA 81, 1030-1034 (1984).
6. Desai, U.R., Petitou, M., Bjork, I. & Olson, S.T. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. J. Biol. Chem. 273, 7478-7487 (1998).
7. Sinay, P. et al. Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin-III. Carbohyd. Res. 132, C5-C9 (1984).
8. Petitou, M. et al. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 398, 417-422 (1999).
9. Vann, W.F., Schmidt, M.A., Jann, B. & Jann, K. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur. J. Biochem. 116, 359-364 (1981).
10. Orellana, A., Hirschberg, C.B., Wei, Z., Swiedler, S.J. & Ishihara, M. Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. J. Biol. Chem. 269, 2270-2276 (1994).
11. Kuberan, B. et al. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry. J. Amer. Chem. Soc. 124, 8707-8718 (2002).
12. 4.5-glycuronidase from flavobacteria. Biochemistry 11, 568-572 (1972).
13. Weber, B., Blanch, L., Clements, P.R., Scott, H.S. & Hopwood, J.J. Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B). Hum. Mol. Genet. 5, 771-777 (1996).
14. Li, J. et al. Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J. Biol. Chem. 272, 28158-28163 (1997).
15. Kusche, M., Hannesson, H.H. & Lindahl, U. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions. Biochem. J. 275, 151-158 (1991).
16. Razi, N. et al. Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide. Biochem. J. 309, 465-472 (1995).
17. Rong, J., Habuchi, H., Kimata, K., Lindahl, U. & Kusche-Gullberg, M. Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. Biochemistry 40, 5548-5555 (2001).
18. Habuchi, H. et al. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J. Biol. Chem. 275, 2859-2868 (2000).
19. Liu, J., Shworak, N.W., Fritze, L.M.S., Edelberg, J.M. & Rosenberg, R.D. Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J. Biol. Chem. 271, 27072-27082 (1996).
20. Liu, J. et al. Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues. J. Biol. Chem. 274, 38155-38162 (1999).
21. Shworak, N.W. et al. Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci. J. Biol. Chem. 274, 5170-5184 (1999).
22. Wu, Z.L., Zhang, L., Beeler, D.L., Kuberan, B. & Rosenberg, R.D. A new strategy for defining critical functional groups on heparan sulfate. FASEB J. 16, 539-545 (2002).